Immune checkpoint signaling modulates T cell function, and our RNA-seq analysis of SK-MEL-28 cells identified PD-L1 as the predominant immune checkpoint regulated by ETV4 in melanoma, consistent with findings in hepatocellular carcinoma [16]. The gene discussed is ETV4; the disease is hepatocellular carcinoma.